CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 07 MAY 2018

NIFTY SPOT UP 28 @ 10647

SENSEX UP 107 @ 35023

BANK NIFTY FUTURES UP 80  @ 25782

HAPPY TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES2: 10800

RES 1:10750

SUP1:10630

SUP2:10570

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES 2: 25950

RES 1: 25850

SUP1: 25700

SUP2: 25600

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

Mcx tips, Intraday stock tips 

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS -03 MAY 2018

CS OPENING BELL:

NIFTY SPOT DOWN 35 @ 10683

SENSEX DOWN 96 @ 35078

BANK NIFTY FUTURES DOWN 68 @ 25574

HAPPY TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES2: 10800

RES 1:10750

SUP1:10650

SUP2:10600

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES 2: 25755

RES 1: 25680

SUP1: 25550

SUP2: 25450

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

mcx-tips, intraday stock tips  

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News:- 31 Jan 2018

Top Headlines Of The Day:- 31 Jan 2018

Amber Enterprises up 4% as Kotak fund buys share in company

Workers at Bajaj Auto plants go on indefinite hunger strike, stock opens weak

BEL approves buy-back of 2.04cr equity shares at Rs182.50 per share

NTPC establishes $6bn MTN Programme on India’s International Exchange

SBI hikes bulk deposit rates by 50-140 basis points

Amber Enterprises up 4% as Kotak fund buys share in company
Shares of Amber Enterprises India rose nearly 4% today after Kotak Fund-India Midcap bought 253,290 shares of the company at Rs1, 149.15 in a bulk deal on the NSE.
Shares of Amber Enterprises got listed on Tuesday at a premium of 37% to their issue price of Rs859.
Amber Enterprises India Ltd is currently trading at Rs 1285, up by Rs 47.75 or 3.86% from its previous closing of Rs 1237.25 on the BSE.
The scrip opened at Rs1, 232.5 and has touched a high and low of Rs1, 298.3 and Rs1, 230, respectively. The current market cap of the company is Rs3, 890.72cr.

Workers at Bajaj Auto plants go on indefinite hunger strike, stock opens weak
Workers at Bajaj Auto Limited’s (BJAUT) plants in Akurdi and Chakan have gone on an indefinite hunger strike from January 29, 2018. The workers’ Union involved in this strike is Vishwa Kalyan Kamgar Sanghatana. BJAUT reported this to stock exchanges on January 30, 2018.
The three reason for workers going on hunger strike are i) pending issue of eight workmen dismissed from services for various acts of misconduct in 2013-14, ii) dismissal of six workmen who did not report to place of transfer/deputation despite court orders and iii) delay in conclusion of wage review process due with effect from April 1, 2016. The matter is pending before the Industrial Court, Pune and High Court of Bombay.

BEL approves buy-back of 2.04cr equity shares at Rs182.50 per share
The board of directors of Bharat Electronics Ltd (BEL), in their meeting held on January 30, 2018, approved the proposal to buy-back the equity shares of the company. The buy-back would be of ~2.04cr equity shares (representing 0.83% of total equity shares) at a price of Rs182.50 per share (~7% premium to the last closing price) payable in cash.
The buy-back size amounts to Rs372.26cr, representing 5% of the aggregate of the fully paid-up equity share capital and free reserves of the company. 
The promoter of the company also intends to participate in the proposed buyback. The buyback is subject to approval from the shareholders and all other applicable statutes. The board has fixed February 9, 2018, as the record date for the buy-back.

NTPC establishes $6bn MTN Programme on India’s International Exchange
India’s largest power producer NTPC has listed its $6bn (about Rs40, 000cr) MTN programme (debt instrument) on India International Exchange at IFSC, GIFT City (India INX). While doing so, NTPC became India’s first quasi-sovereign company to list at India INX.
The Listing was done on January 24, 2018, on the Global Securities Market of India INX; India’s first international exchange.
The listing will help NTPC raise funds at lower costs from international investors and also allow foreign investors to access good quality Indian debt paper.

SBI hikes bulk deposit rates by 50-140 basis points
SBI announced that the leading banker is going to increase bulk deposit rates by 50-140 bps effective today. Following this announcement, shares of SBI reached a high of Rs318.8 in the morning trade, gaining ~2%. However, the stock was unable to hold on to the gains as the day progressed.
The stock ended at Rs312.85, up by Rs1.75 or 0.56% from its previous closing of Rs311.1 on the BSE. The scrip opened at Rs311.05 and has touched a high and low of Rs318.75 and Rs310.8 respectively.
The bank’s FY17 consolidated loan book stood at Rs.19.5 lakh cr. Its consolidated GNPA & NNPA stood at 9.1% & 5.2% as of FY17.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News :- 30 Jan 2018

Top Headlines Of The Day:- 30 Jan 2018

Jubilant receives ANDA approval for Clonidine Hydrochloride ER Tablets

KPIT and Birlasoft to come together to create two entities

Mylan and Biocon receive positive CHMP opinion for Insulin Glargine

Amber Enterprises lists at 38% premium to issue price

HCL Tech gets 5-year order from Cadent for IT Infra services

Jubilant receives ANDA approval for Clonidine Hydrochloride ER Tablets
Jubilant Life Sciences has announced that its material wholly owned subsidiary Jubilant Pharma Limited has received Abbreviated New Drug Application (ANDA) final approval for Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg. This is a generic version of Kapvay of Concordia. It is used for the treatment of attention deficit hyperactivity disorder (ADHD).
As on December 31, 2017, Jubilant had a total of 86 ANDAs for Oral Solids filed in the US of which 56 had been approved and 12 Injectable filings of which 10 had been approved. This is the eighth USFDA approval in FY18.

Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg had annual sales of ~USD 66 million in the US as per IMS MAT Jun 2017. 

KPIT and Birlasoft to come together to create two entities
KPIT Technologies had informed the exchanges that its board had approved a draft composite scheme for amalgamation of Birlasoft (India) with KPIT. The second leg of the transaction would involve demerger of the engineering business of the company into KPIT Engineering Limited (KEL), a wholly owned subsidiary of the company and will be renamed as KPIT Technologies Limited.
According to the arrangement, shareholders of Birlasoft will receive 22 equity shares of the combined KPIT -Birlasoft for every nine equity shares of Birlasoft. the combined KPIT-Birlasoft will be engaged in the ITSS Business, and pursuant to the Proposed Demerger, KEL's shares will be listed and shareholders of combined KPIT-Birlasoft will receive one share of KEL for each share they hold in the combined KPIT-Birlasoft.

Mylan and Biocon receive positive CHMP opinion for Insulin Glargine
Biocon has announced that it, along with its partner Mylan, has received a positive opinion from Europen Medical Agency’s (EMA) - Committee for Medicinal Products for Human Use (CHMP) - for insulin Glargine. CHMP has also recommended approval to Insulin Glargine, which will be sold under brand Semglee.
There are ~60m people affected by diabetes in Europe with an increasing prevalence in the region. Insulin Glargine is a biosimilar, which will be available for commercialization once it receives EMA approval.
Biocon and Mylan are also awaiting approval for Insulin Glargine in Australia, Canada, and the US and are planned for key Emerging Markets.

Amber Enterprises lists at 38% premium to issue price
Amber Enterprises listed at a significant premium of 38% to its issue price of Rs855-859 and is currently trading at Rs1, 187.2.
The IPO offer consisted of Fresh Issue of 55.3 lakh shares (aggregating up to ~Rs475cr) at the upper end of the price band. It also includes an offer for sale of up to 14.6 lakh shares (Rs125cr) by the promoters. The issue proceeds will be used for pre-payment or repayment of borrowings (~Rs400cr) and for other general corporate purposes (~Rs75cr).

HCL Tech gets 5-year order from Cadent for IT Infra services
HCL Technologies (HCL) announced a five-year IT infrastructure services and application management contract with Cadent, the UK’s largest gas distribution network. The ground-breaking ‘cloud first’ multi-service deal will see HCL provide integrated public cloud hosting and SAP and Application Maintenance Services, including the migration of a significant applications portfolio to Amazon Web Services (AWS) public cloud. In addition, HCL will provide IT Service Management, Service Desk and Managed Workplace Services.
HCL will deliver these services to support Cadent’s business operations which distributes gas to 11 million homes and businesses in the North West, Midlands, East and South East of England. HCL will provide MWS support to approximately 4,500 staff; including 3,500 field based-engineers who work across the company’s 65 regional depots.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News :- 29 Jan 2018

Top Headlines Of The Day :- 29 Jan 2018

Avenue Supermarts Ltd (DMart), up 5% after announcing Q3FY18 results, PAT up 65.8% yoy
Cipla, Aurobindo and Strides Shasun receive final approval for gViread
Havells to set up a manufacturing unit in Rajasthan for an investment of Rs360cr
DLF is looking to launch QIP of shares by April, 2018
Idea Cellular seeks government approval for raising FDI limit to 100%

Avenue Supermarts Ltd (DMart), up 5% after announcing Q3FY18 results, PAT up 65.8% yoy
DMart rallies 5% after announcing Q3FY18 results. In Q3FY18, its revenue grew by 22.6% yoy to Rs4, 095cr. EBITDA came in at Rs422cr, up 46.3% yoy . EBITDA margin expanded by 167bps yoy to 12.3% due to an improvement in sales mix and efficiency of centralized procurement. Adjusted PAT increased by 65.8% yoy to Rs252cr.
Board has also approved acquisition of 50.8% paid-up share capital of Avenue E-Commerce Limited for Rs49.2cr. Post-acquisition it will become wholly owned subsidiary. Heavy discounts to attract price sensitive customers and losses of the e-commerce entity will offset the margin gains.

Cipla, Aurobindo and Strides Shasun receive final approval for gViread
Cipla, Aurobindo and Strides Shasun have received final approval for their Abbreviated New Drug Application (ANDA) for Tenofovir Disoproxil Fumarate Tablets, 300mg, from the USFDA. This is a generic version of Gilead Sciences' Viread Tablets, 300mg which is indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in adults. The final approval means that product is available for immediate commercialization in the US.
Viread 300mg tablets had annual US sales of approximately $725-750mn as per IMS Health. An orange book search on USFDA website indicates that Aurobindo, Cipla, Teva, Macleods Pharmaceuticals and Strides Shasun, all have received approval for this drug on January 26, 2018. Approval for five different filers on the same day is likely to see competition for the Viread 300mg tablets.

Havells to set up a manufacturing unit in Rajasthan for an investment of Rs360cr
Havells is setting-up a new facility at Ghiloth, Neemrana, Rajasthan to manufacture consumer durables, as per the BSE filing. The total estimated cost for the project is Rs360cr (ex-land cost, as the company already owns the land), spread over a period of 3 years. The total investment will be funded through a mix of internal accruals and borrowings. Company expects to start the production from Q3FY19E.
For this investment, the company will be entitled to investment subsidy under the M-SIPS (Modified Special Incentive Package Scheme) introduced by MEITY and also for various tax/ levies and other benefits from the State Government of Rajasthan.

DLF is looking to launch QIP of shares by April, 2018
DLF is looking to launch its qualified institutional placement (QIP) of shares by April 2018, according to a media report.
DLF has already received approval from shareholders to sell 173-million equity shares, which will be determined by the formula laid down by the market regulator Securities and Exchange Board of India. The company may raise Rs4500-5000cr from the QIP.

Idea Cellular seeks government approval for raising FDI limit to 100%
Telecom operator Idea Cellular has made an application to the DIPP (Department of Industrial Policy and Promotion) for raising the FDI limit in Idea to 100%. Foreign investors holdings in Idea Cellular stood at ~27% stake as on December 2017. While 100% FDI is allowed in telecom companies, investments under the automatic route are allowed up to 49%.
At present, Idea Cellular is in the process of merging its telecom business with the Indian unit of Vodafone. As per latest industry data from Trai, Idea and Vodafone jointly have 40.5cr mobile subscribers. This would potentially give the joint entity the largest subscriber base in the Indian telecom segment. Vodafone is expected to hold around 47.5% stake in the merged entity and rest will be owned by Idea and its promoter Aditya Birla Group.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: News that mattered during the week: 20 Jan 2018

Important news that made headlines during the week.

• Biocon enters into a global partnership with Sandoz to develop, manufacture and commercialize multiple biosimilars in immunology and oncology
• Torrent Pharma acquires US-based generic pharmaceuticals Bio-Pharma Inc
• Tech Mahindra to acquire 17.5% shares of Altiostar on a fully diluted basis
• TCS expands partnership with Shure Inc to establish global development center
• Housing Finance gets RBI nod for US $500mn masala bonds
• Adani Power gets 49% stake in 600 MW Korba West Power
• Varun Beverages to acquire franchisee rights for Pepsico India in the state of Bihar
• Sun Pharma got a license to sell the generic version of Linzess in the US from February 1, 2031, after settling patent litigation
• GAIL, Gazprom sign pact for re-negotiated long-term LNG sale
• Texmaco Rail considering setting up logistics hub and food park in West Bengal
• Kotak Mahindra is mulling divesting its stake in MCX
• Bajaj Finance to hold 12.6% stake in Mobikwik on a fully diluted basis post-conversion of Compulsorily Convertible Preference Shares for a total investment of Rs225cr

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CapitalStars Market Ad On CNBC Awaaz, Pehla Kadam Date 18 Dec 2017

CapitalStars Market Ad On CNBC Awaaz, Pehla Kadam Date 18 Dec 2017

CapitalStars Award Winning, SEBI registered, ISO certified investment advisory company. We provide intraday & positional services in equity , derivative ,commodity & currency. Our research team is highly skilled & experienced please contact 0731-6690000.

Visit Our Site- http://capitalstars.com/video-gallery

CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY  -

 CAPITALSTARS CALL US  9977499927

Equity Tips , Intraday Stock Tips , FreeTrading Tips  , Sebi Registered advisory Company , Capitalstars Video Gallery

Investment  & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CapitalStars Market Expert Calls On Zee Business Dated 22 Nov 2017

CapitalStars Market Expert Calls On Zee Business Dated 22 Nov 2017 

CapitalStars Award Winning , SEBI registered , ISO certified investment advisory company. We provide intraday & positional services in equity , derivative ,commodity & currency. Our research team is highly skilled & experienced please contact 0731-6690000.

Visit Our Site- http://capitalstars.com/video-gallery

Click here -  Free Trading tips , equity Tips , sebi registered advisory company , Mcx Tips  ,  Capitalstars , Intraday Stock tips , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS - 03 JUN 2016

CS NIFTY FUTURES (JUNE) OVERVIEW

TREND MIXED TO BULLISH

RES2:8295

RES 1:8255     

SUP1:8155

SUP2:8115

CS BANK NIFTY FUTURES (JUNE) OVERVIEW

TREND MIXED TO BULLISH

RES 2:17755

RES 1:17675

SUP1:17325

SUP2:17275

                                                  

Get real time advice for Intraday Trading Tips , Share Market Tips  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Top 5 Things to Know In the Market on Thursday

Here are the top five things you need to know in financial markets on Thursday, June 2:

1. OPEC meets in Vienna
The Organization of the Petroleum Exporting Countries’ closely-monitored meeting kicked off in Vienna at 08:00GMT, or 4:00AM ET. The oil cartel is due to release a statement following the conclusion of the summit at around 14:00GMT, or 10:00AM ET, although no dramatic announcement on a production cut is expected.
Speaking to journalists ahead of the meeting, Saudi Arabia’s oil minister, Khalid Al-Falih, said the oil group’s strategy of letting the market rebalance itself out on its own appeared to be working.
Brent was up 25 cents, or 0.5%, at $49.97 a barrel by 9:55GMT, or 5:55AM ET, after rising to a high of $50.30, while U.S. crude tacked on 20 cents, or 0.4%, to $49.21.
Traders will also eye weekly government stockpile data from the U.S. due at 15:00GMT, or 11:00AM ET, amid expectations for a drop of 2.5 million barrels.

2. ECB policy decision, Draghi in focus
The European Central Bank's interest rate decision is due at 11:45GMT, or 7:45AM ET, with most of the focus likely to be on President Mario Draghi's press conference 45 minutes after the announcement. The consensus is that the ECB will stand pat on rates and reaffirm its focus on implementing the stimulus package announced in March.
The ECB will also release updated inflation and growth forecasts, with some analysts expecting the bank to raise its projections for inflation and growth.

3. U.S. employment data due ahead of the bell
The U.S. was to release the ADP jobs report for May at 12:15GMT, or 8:15AM ET, followed by weekly jobless claims data at 12:30GMT, or 8:30AM ET.
Market players are also focusing on Friday's U.S. nonfarm payrolls report. The consensus forecast is that the data will show jobs growth of 162,000 last month, following an increase of 160,000 in April, the unemployment rate is forecast to dip to 4.9%, while average hourly earnings are expected to rise 0.2% after gaining 0.3% a month earlier.
Solid readings could further heighten expectations for a move as soon as the Federal Reserve's next policy meeting on June 14-15.
Traders are now pricing in a 20% chance for a rate hike in June and 58% in July, according to CME Group's (NASDAQ:CME) FedWatch tool. September odds were at about 66%.

4. Global stocks mostly higher ahead of key risk events
U.S. stock futures pointed to a flat open on Thursday, as market players looked ahead to key U.S. data later in the day for more clues on the Federal Reserve’s next move.
Elsewhere, European stock markets were marginally higher, as investors waited to hear about monetary policy from the European Central Bank and oil output policy from the Organization of the Petroleum Exporting Countries.
Earlier, Japan's Nikkei tumbled 2% after the government moved to delay a sales-tax hike for more than two years, bucking mostly higher markets around the region.

5. Dollar moves further away from 2-month highs
The U.S. dollar retreated further from a two-month high against a basket of major currencies early Thursday. The dollar index was down 0.15% at 95.28, moving further away from Monday’s two-month peak of 95.96.

The greenback fell to a two-week low of 108.84 against the yen and was last down 0.5% at 109.01 (USD/JPY), while the euro touched a two-week peak of 1.1220 and last traded at 1.1202, up 0.1% (EUR/USD).

                                             

Get real time advice for Intraday Trading Tips , Share Market Tips  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

TOP CORPORATE NEWS - 27 May 2016

IOC Q4 Net Profit comes at Rs1,236 Cr

IOC Q4 Net Profit comes at Rs1, 236 Cr

Total Income at Rs.80, 449.7 Cr

EBITDA at Rs.10, 044 Cr

EBITDA Margin At 5%

GRM At $3/bbl Vs $6/bbl (QoQ)

Canara Bank Q4: Net Loss at Rs3,905 Cr

Canara Bank Q4: Net Loss at Rs3, 905 Cr

Gross NPA At 9.4% Vs 5.84% (QoQ)

Gross NPA +59.7% at Rs.31, 638 Cr Vs Rs.19, 813 Cr (QoQ)

Net NPA At 6.42% Vs 3.90% (QoQ)

Tax Write-back At Rs.779.5 Cr Vs Expense of Rs.110 Cr (YoY)

Provisions at Rs.6, 331 Cr Vs Rs.1, 429 Cr (QoQ)

NII -4.5% at Rs.2, 374 Cr Vs Rs.2, 486 Cr (YoY)

SBI Q4FY16: Mixed Bag performance, Asset quality worsens

State Bank of India Q4FY16 results first cut: Mixed Bag performance

SBI Q4: Net Profit -66.2% At Rs.1,264 Cr Vs Rs.3,742 Cr (YoY)

Gross NPA +34.9% At Rs.98,172 Cr Vs Rs.72,791 Cr (QoQ)

Gross NPA At 6.5% Vs 5.1% (QoQ)

Net NPA At 3.81% Vs 2.89% (QoQ)

Net NPA +38.7% At Rs.55,807 Cr Vs Rs.40,249 Cr (QoQ)

Slippages At Rs.30,312 Cr Vs Rs.20,692 Cr (QoQ)

Provisions For NPA At Rs.12,139.2 Cr Vs Rs.7,644.6 Cr (QoQ)

Lupin gains on receiving EIR for Mandideep facility

Shares of Lupin gained 3% to Rs1507 on NSE on back of reports that the company has got Establishment Inspection Report (EIR) for its Mandideep facility.

This is sentimentally positive for Lupin; stock is up by 3%; USFDA clearance for Goa plant will be key to watch for going forward.

Torrent Pharma in talks to buy Glochem Industries for Rs300 crore

Torrent Pharma in talks to buy Glochem Industries for Rs300 crore – Long term positive for Torrent if deal goes thru

Torrent Pharma is in advanced talks to buy bulk drugs supplier Glochem Industries for about Rs300 crore.

Glochem is a medium-sized company that makes bulk drugs, or active ingredients, which are used as raw material for medicines and has USFDA approved sites in Hyderabad and Vizag where oral bulk actives are manufactured.

Our Some Best Services Read it Here…

Commodity Market Tips, MCX Copper Tips, MCX Tips, Crude oil tips, Nifty Options Tips, Share Market Live, Financial Advisory Company in Indore, Stock Advisory Company in Indore

 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900